New Delhi: With Hyderabad based Bharat Biotech coming up with the first COVID-19 vaccine Covaxin, there’s another potential vaccine for the deadly virus that has got the DCGI nod for clinical trials on humans in India.
This vaccine is developed by Zydus Cadilla and has also bagged the go-ahead from the DCGI to start trials.
The approval process for human was fast-tracked after the subject expert committee recommended the use, keeping in mind the emergency and immediate medical need during the pandemic.
“DCGI Dr VG Somani has given approval for the phase I and II clinical trials (on humans) of the potential novel coronavirus vaccine developed by Zydus Cadila Healthcare Ltd on Thursday after its animal studies was found to be successful,” an official source was quoted as saying by news agency PTI.
New Delhi: The Supreme Court on Friday dismissed a Habeas Corpus petition filed by a…
New Delhi: Surrounded by heavy security, Bollywood actor Salman Khan arrived on the set of…
Bhubaneswar: The regional centre of India Meteorological Department (IMD) has issued nowcast warning for 12…
Jajpur/Koraput: Two separate incidents of theft have turned the light on safety of tourists in…
Bhubaneswar: The Odisha government has reconstituted a task force to suggest measures for implementing the…
Bhubaneswar: Congress Odisha in-charge Ajoy Kumar has questioned the timing of the case registered against…
New Delhi: Almost 11 months after the US first accused an unnamed Indian official, CC-1,…
Srinagar: In his first cabinet meeting on Thursday, Jammu and Kashmir Chief Minister Omar Abdullah introduced…